Decibel Therapeutics Stock

decibeltx.comBioTechFounded: 2015Funding to Date: $132.06MM

Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, one of the largest areas of unmet need in medicine.

Register for Details

For more details on financing and valuation for Decibel Therapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Decibel Therapeutics.

Register Today
Register for Details

For more details on financing and valuation for Decibel Therapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Steven Holtzman
Chairman
Paula Cobb
Chief Operating Officer
Shin-San Michael Su Ph.D
Chief Scientific Officer
John Keilty
Chief Data Sciences Officer
Leslie Shinobu MD
Chief of Translational Research
Anna Trask
Chief People, Community and Culture Officer
Albert Edge Ph.D
Co-Founder & Scientific Advisory Board Member
Charles Liberman Ph.D
Co-Founder & Scientific Advisory Board Member
Gabriel Corfas Ph.D
Co-Founder & Member of Scientific Advisory Board
Ulrich Müller Ph.D
Co-Founder & Member of Scientific Advisory Board

Board Members

Anthony Philippakis MD
GV
Craig Muir
Third Rock Ventures
Gabriel Corfas Ph.D
George Scangos Ph.D
Jeffrey Jonas MD
Jens Eckstein Ph.D
SR One
Neil Exter
Third Rock Ventures
Roger Brown
Steven Holtzman
Troyen Brennan MD
Ulrich Müller Ph.D

Other companies like Decibel Therapeutics in the BioTech sector

Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$1.3B
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.89B

News

Decibel Therapeutics announces appointment of biopharmaceutical leader Christine A. Poon to its board of directors.
Decibel Therapeutics, which discovers and develops medicines to treat hearing loss and hearing-related disorders, raised $55M in Series C funding